Cristiano Ronaldo, the captain of the Portuguese national team, has made a strategic investment by contributing approximately €6.4 million (around $6.9 million) to become a 10% shareholder in Pro2col, a health technology company. This investment deepens his historical partnership with Herbalife, which has lasted since 2013, aiming to leverage advanced technology centered on artificial intelligence and data to deliver personalized nutrition and fitness plans.

The initiative focuses on creating a digital platform that utilizes artificial intelligence to offer individualized health solutions, highlighting the Pro2Score tool designed to monitor vital signs. Ronaldo, who now plays for the Saudi Arabian club Al-Nassr, described this investment as a "natural evolution" of his role as a brand ambassador and emphasized his desire to contribute to transforming how individuals approach their well-being.

Steve Graziani, the CEO of Herbalife, expressed that this collaboration marks the beginning of a new chapter based on technology and innovation. The news of Ronaldo's investment is expected to have both a financial impact and an influence on the health and wellness industry, showcasing the growing intersection between sports, technology, and personal health management.